The main focus of the Bettelli Lab is to identify the cell types of the immune system and mechanisms, which induce and regulate the development of autoimmunity.
Estelle Bettelli, PhD
Pushpa Palle, PhD
Yevgeniy Yuzefpolskiy, PhD
What Do T Cells Like to Eat? The Answer Could Stop Multiple Sclerosis
Do MS Treatments Make Vaccines Less Effective?
This issue of vaccine efficacy has taken center stage in light of the pandemic. A BRI team led by Estelle Bettelli, PhD, and Yevgeniy Yuzefpolskiy, PhD, recently made key findings about how three different medicines for multiple sclerosis (MS) impact response to COVID-19 vaccines.
Taking on Multiple Sclerosis
Dr. Bettelli’s team develops sophisticated MS models to investigate its mysteries and pursue innovative therapies. We recently asked her for an update on BRI’s MS progress.